Ads
related to: labcorp and invitae test
Search results
Results From The WOW.Com Content Network
Invitae's estimated assets were in the $500 million - $1 billion range, while its liabilities were in the $1 billion - $10 billion range, according to the bankrup ... Clinical lab operator Labcorp ...
Invitae Corp. is a biotechnology company that was created as a subsidiary of Genomic Health in 2010 and then spun-off in 2012. [2] In 2017, Invitae acquired Good Start Genetics and CombiMatrix. [3] [4] In 2020, Invitae announced the acquisition of ArcherDX for $1.4 billion. [5]
Labcorp has been criticized over faulty paternity tests, many of which have resulted in lawsuits. The most notable case was the 2005 false accusation of Washington hairdresser Andre Chreky, who spent $200,000 and years in court proving, despite a false-positive test, that he was not the father.
Shares of the San Francisco-based company tumbled 69% to hit a record low of 11 cents after the report. An Invitae spokesperson told Reuters that the company did not comment on market rumors and ...
In June 2021, the company changed its name to Labcorp Drug Development. [55] In February 2023, the company was renamed Fortrea Holdings. [56] In July 2023, Labcorp completed the corporate spin-off of the company. [57] In June 2024, the company sold its Endpoint Clinical and Fortrea Patient Access businesses to Arsenal Capital Partners. [58]
LabCorp (LH) continues to strengthen foothold in the diagnostics space through organic and inorganic means. Skip to main content. 24/7 Help. For premium support please call: 800-290-4726 more ...